|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lipworth L, Tarone RE and McLaughlin JK:
The epidemiology of renal cell carcinoma. J Urol. 176:2353–2358.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Paner GP, Stadler WM, Hansel DE, Montironi
R, Lin DW and Amin MB: Updates in the eighth edition of the
tumor-node-metastasis staging classification for urologic cancers.
Eur Urol. Jan 8–2018.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dasgupta P, Kulkarni P, Majid S, Varahram
S, Hashimoto Y, Bhat NS, Shiina M, Deng G, Saini S, Tabatabai ZL,
et al: MicroRNA-203 inhibits long noncoding RNA HOTAIR and
regulates tumorigenesis through epithelial-to-mesenchymal
transition pathway in renal cell carcinoma. Mol Cancer Ther. Feb
13–2018.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hu B, Wang J and Jin X: MicroRNA-138
suppresses cell proliferation and invasion of renal cell carcinoma
by directly targeting SOX9. Oncol Lett. 14:7583–7588.
2017.PubMed/NCBI
|
|
6
|
Duns G, van den Berg E, van Duivenbode I,
Osinga J, Hollema H, Hofstra RM and Kok K: Histone
methyltransferase gene SETD2 is a novel tumor suppressor gene in
clear cell renal cell carcinoma. Cancer Res. 70:4287–4291. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kapur P, Peña-Llopis S, Christie A,
Zhrebker L, Pavía-Jiménez A, Rathmell WK, Xie XJ and Brugarolas J:
Effects on survival of BAP1 and PBRM1 mutations in sporadic
clear-cell renal-cell carcinoma: A retrospective analysis with
independent validation. Lancet Oncol. 14:159–167. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gossage L, Murtaza M, Slatter AF,
Lichtenstein CP, Warren A, Haynes B, Marass F, Roberts I, Shanahan
SJ, Claas A, et al: Clinical and pathological impact of VHL, PBRM1,
BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma.
Genes Chromosomes Cancer. 53:38–51. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang S, Xu J and Zeng X: A six-long
non-coding RNA signature predicts prognosis in melanoma patients.
Int J Oncol. Feb 7–2018.(Epub ahead of print). View Article : Google Scholar
|
|
12
|
Chen X, Chen Z, Yu S, Nie F, Yan S, Ma P,
Chen Q, Wei C, Fu H, Xu T, et al: Long noncoding RNA LINC01234
functions as a competing endogenous RNA to regulate CBFB expression
by sponging miR-204-5p in gastric cancer. Clin Cancer Res. Jan
31–2018.(Epub ahead of print). View Article : Google Scholar
|
|
13
|
Wan L, Sun M, Liu GJ, Wei CC, Zhang EB,
Kong R, Xu TP, Huang MD and Wang ZX: Long noncoding RNA PVT1
promotes non-small cell lung cancer cell proliferation through
epigenetically regulating LATS2 expression. Mol Cancer Ther.
15:1082–1094. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sarver AL, Murray CD, Temiz NA, Tseng YY
and Bagchi A: MYC and PVT1 synergize to regulate RSPO1 levels in
breast cancer. Cell Cycle. 15:881–885. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang XW, Bu P, Liu L, Zhang XZ and Li J:
Overexpression of long non-coding RNA PVT1 in gastric cancer cells
promotes the development of multidrug resistance. Biochem Biophys
Res Commun. 462:227–232. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cancer Genome Atlas Research Network:
Comprehensive molecular characterization of clear cell renal cell
carcinoma. Nature. 499:43–49. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mermel CH, Schumacher SE, Hill B, Meyerson
ML, Beroukhim R and Getz G: GISTIC2.0 facilitates sensitive and
confident localization of the targets of focal somatic copy-number
alteration in human cancers. Genome Biol. 12:R412011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Song W, Dang Q, Xu D, Chen Y, Zhu G, Wu K,
Zeng J, Long Q, Wang X, He D and Li L: Kaempferol induces cell
cycle arrest and apoptosis in renal cell carcinoma through EGFR/p38
signaling. Oncol Rep. 31:1350–1356. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liang L, Li L, Zeng J, Gao Y, Chen YL,
Wang ZQ, Wang XY, Chang LS and He D: Inhibitory effect of silibinin
on EGFR signal-induced renal cell carcinoma progression via
suppression of the EGFR/MMP-9 signaling pathway. Oncol Rep.
28:999–1005. 2012.PubMed/NCBI
|
|
21
|
Clark BS and Blackshaw S: Long non-coding
RNA-dependent transcriptional regulation in neuronal development
and disease. Front Genet. 5:1642014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li P, Ruan X, Yang L, Kiesewetter K, Zhao
Y, Luo H, Chen Y, Gucek M, Zhu J and Cao H: A liver-enriched long
non-coding RNA, lncLSTR, regulates systemic lipid metabolism in
mice. Cell Metab. 21:455–467. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Carrieri C, Forrest AR, Santoro C,
Persichetti F, Carninci P, Zucchelli S and Gustincich S: Expression
analysis of the long non-coding RNA antisense to Uchl1 (AS Uchl1)
during dopaminergic cells' differentiation in vitro and in
neurochemical models of Parkinson's disease. Front Cell Neurosci.
9:1142015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsoi LC, Iyer MK, Stuart PE, Swindell WR,
Gudjonsson JE, Tejasvi T, Sarkar MK, Li B, Ding J, Voorhees JJ, et
al: Analysis of long non-coding RNAs highlights tissue-specific
expression patterns and epigenetic profiles in normal and psoriatic
skin. Genome Biol. 16:242015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang HM, Yang FQ, Chen SJ, Che J and
Zheng JH: Upregulation of long non-coding RNA MALAT1 correlates
with tumor progression and poor prognosis in clear cell renal cell
carcinoma. Tumour Biol. 36:2947–2955. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hirata H, Hinoda Y, Shahryari V, Deng G,
Nakajima K, Tabatabai ZL, Ishii N and Dahiya R: Long noncoding RNA
MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and
interacts with miR-205. Cancer Res. 75:1322–1331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qiao HP, Gao WS, Huo JX and Yang ZS: Long
non-coding RNA GAS5 functions as a tumor suppressor in renal cell
carcinoma. Asian Pac J Cancer Prev. 14:1077–1082. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xue S, Li QW, Che JP, Guo Y, Yang FQ and
Zheng JH: Decreased expression of long non-coding RNA NBAT-1 is
associated with poor prognosis in patients with clear cell renal
cell carcinoma. Int J Clin Exp Pathol. 8:3765–3774. 2015.PubMed/NCBI
|
|
29
|
Wu Y, Liu J, Zheng Y, You L, Kuang D and
Liu T: Suppressed expression of long non-coding RNA HOTAIR inhibits
proliferation and tumourigenicity of renal carcinoma cells. Tumour
Biol. 35:11887–11894. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Takahashi Y, Sawada G, Kurashige J, Uchi
R, Matsumura T, Ueo H, Takano Y, Eguchi H, Sudo T, Sugimachi K, et
al: Amplification of PVT-1 is involved in poor prognosis via
apoptosis inhibition in colorectal cancers. Br J Cancer.
110:164–171. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tseng YY, Moriarity BS, Gong W, Akiyama R,
Tiwari A, Kawakami H, Ronning P, Reuland B, Guenther K, Beadnell
TC, et al: PVT1 dependence in cancer with MYC copy-number increase.
Nature. 512:82–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Surendran K, Selassie M, Liapis H, Krigman
H and Kopan R: Reduced Notch signaling leads to renal cysts and
papillary microadenomas. J Am Soc Nephrol. 21:819–832. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Martinou JC and Youle RJ: Mitochondria in
apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev
Cell. 21:92–101. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kaufmann T, Strasser A and Jost PJ: Fas
death receptor signalling: Roles of Bid and XIAP. Cell Death
Differ. 19:42–50. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wei MC, Zong WX, Cheng EH, Lindsten T,
Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB and
Korsmeyer SJ: Proapoptotic BAX and BAK: A requisite gateway to
mitochondrial dysfunction and death. Science. 292:727–730. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tewari M, Quan LT, O'Rourke K, Desnoyers
S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS and Dixit VM:
Yama/CPP32 beta, a mammalian homolog of CED-3, is a
CrmA-inhibitable protease that cleaves the death substrate
poly(ADP-ribose) polymerase. Cell. 81:801–809. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sherr CJ: Cancer cell cycles. Science.
274:1672–1677. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chandra A, Lan S, Zhu J, Siclari VA and
Qin L: Epidermal growth factor receptor (EGFR) signaling promotes
proliferation and survival in osteoprogenitors by increasing early
growth response 2 (EGR2) expression. J Biol Chem. 288:20488–20498.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhan Y, Chen Y, Liu R, Zhang H and Zhang
Y: Potentiation of paclitaxel activity by curcumin in human breast
cancer cell by modulating apoptosis and inhibiting EGFR signaling.
Arch Pharm Res. 37:1086–1095. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen W, Zhong X, Wei Y, Liu Y, Yi Q, Zhang
G, He L, Chen F, Liu Y and Luo J: TGF-β regulates survivin to
affect cell cycle and the expression of EGFR and MMP9 in
glioblastoma. Mol Neurobiol. 53:1648–1653. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sigismund S, Avanzato D and Lanzetti L:
Emerging functions of the EGFR in cancer. Mol Oncol. 12:3–20. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chou YT, Lin HH, Lien YC, Wang YH, Hong
CF, Kao YR, Lin SC, Chang YC, Lin SY, Chen SJ, et al: EGFR promotes
lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc
pathway that targets the Ets2 transcriptional repressor ERF. Cancer
Res. 70:8822–8831. 2010. View Article : Google Scholar : PubMed/NCBI
|
